Literature DB >> 16105765

Granulocyte colony-stimulating factor-primed donor lymphocyte infusion after salvage chemotherapy for treatment of relapsed acute leukemia after allogeneic stem cell transplantation.

Takeshi Kobayashi, Kazuteru Ohashi, Miwa Sakai, Takuya Yamashita, Yoshiki Okuyama, Kiyoshi Hiruma, Hideki Akiyama, Hisashi Sakamaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16105765     DOI： 10.1532/IJH97.05039

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  11 in total

1.  Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.

Authors:  F Keil; E Prinz; P Kalhs; K Lechner; K Moser; I Schwarzinger; U Jäger; C Fonatsch; N Worel; C Mannhalter; W Rabitsch; H Loidolt; A Schulenburg; M Mitterbauer; P Höcker; H T Greinix
Journal:  Leukemia       Date:  2001-03       Impact factor: 11.528

2.  Treatment of Relapsing Ph+ Acute Lymphoblastic Leukemia with Donor Leukocyte Infusion Followed by Quantitative Monitoring of Residual Disease.

Authors:  N Kono; K Ohashi; Y Okuyama; S Mori; K Hiruma; H Akiyama; T Fukui; K Osumi; H Sakamaki
Journal:  Hematology       Date:  2001       Impact factor: 2.269

3.  Relapse after allogeneic bone marrow transplantation for acute leukaemia: a survey by the E.B.M.T. of 117 cases.

Authors:  F Frassoni; A J Barrett; A Grañena; P Ernst; G Garthon; H J Kolb; H G Prentice; J P Vernant; F E Zwaan; A Gratwohl
Journal:  Br J Haematol       Date:  1988-11       Impact factor: 6.998

Review 4.  Leukemia relapse after allogeneic bone marrow transplantation: a review.

Authors:  S A Giralt; R E Champlin
Journal:  Blood       Date:  1994-12-01       Impact factor: 22.113

5.  Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.

Authors:  R Martino; R Guardia; A Altés; A Sureda; S Brunet; J Sierra
Journal:  Haematologica       Date:  1999-03       Impact factor: 9.941

6.  Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.

Authors:  R Martino; M Bellido; S Brunet; A Altés; A Sureda; R Guárdia; A Aventín; J F Nomdedéu; A Domingo-Albós; J Sierra
Journal:  Haematologica       Date:  1999-06       Impact factor: 9.941

7.  Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation.

Authors:  John E Levine; Thomas Braun; Samuel L Penza; Patrick Beatty; Kenneth Cornetta; Rodrigo Martino; William R Drobyski; A John Barrett; David L Porter; Sergio Giralt; Jose Leis; Houston E Holmes; Matthew Johnson; Mary Horowitz; Robert H Collins
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

8.  Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.

Authors:  B Glass; I Majolino; P Dreger; R Scimè; A Santoro; S Vasta; M Suttorp; T Haferlach; N Schmitz
Journal:  Bone Marrow Transplant       Date:  1997-10       Impact factor: 5.483

9.  Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse.

Authors:  S-J Choi; J-H Lee; J-H Lee; S Kim; M Seol; Y-S Lee; J-S Lee; W-K Kim; H-S Chi; K-H Lee
Journal:  Leukemia       Date:  2004-11       Impact factor: 11.528

10.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Authors:  H J Kolb; A Schattenberg; J M Goldman; B Hertenstein; N Jacobsen; W Arcese; P Ljungman; A Ferrant; L Verdonck; D Niederwieser; F van Rhee; J Mittermueller; T de Witte; E Holler; H Ansari
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.